LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Medtronic Invests in ASC Bundled Payment Services Provider
Legal & Regulatory and Reimbursement

Medtronic Invests in ASC Bundled Payment Services Provider

July 20, 2018 2 min read Premium comments

Advertisement

Medtronic Invests in ASC Bundled Payment Services Provider
Courtesy of Revo Health
#medtronicSecondary#bundledpayments#revohealth

Medtronic plc wants a better understanding of how bundled payments work at ambulatory surgery centers (ASCs). In recent years the company has started providing services to health care providers in the hospital setting.

To gain that ASC understanding, the company invested in a company, spun off from Twin Cities Orthopedics (TCO), called Revo Health, LLC.

Revo Health was launched in 2017 by TCO to advise physician groups on how to start and manage bundled-payment programs.

Bundled Payment Initiative

In July 2015, the Centers for Medicare & Medicaid Services (CMS) announced a 90-day mandated bundled payment model called the Comprehensive Care for Joint Replacement initiative (CJR).

The Trump Administration scrapped the mandatory part in 2017 and made participation voluntary with the “Bundled Payment for Care Improvement (BPCI) Advanced Model.”

As we reported in April, private payers followed suit with their own versions. Today, approximately one-third of all healthcare providers are involved with a bundled payment style program—whether CMS or private payor.

In a previous article UnitedHealthcare, the largest private payer, told OTW: “To date, more than 15 million people, or nearly one in every three people enrolled in UnitedHealthcare benefit plans, currently access care from providers in value-based care relationships.”

Advertisement

The BPCI Advanced Model, also referred to as Advanced Alternative Payment Model, will officially start enrolling patients in October 2018 and will run through the end of 2023.

Results

The program will likely incentivize more outpatient (and presumably less expensive) care. At its last annual meeting, the American Academy of Orthopaedic Surgeons shared data which compared the effects of BPCI on physician groups versus acute care hospitals. The result? Physician group practices performed much better than acute care hospitals under the bundled care model. So, Medtronic has a big incentive to understand the program from their customers’ viewpoint.

Owen O’Neill, M.D., a surgeon at TCO who also serves on Revo’s board, told the Minneapolis/St. Paul Business Journal on July 18, 2018, that TCO has offered bundled payment programs through its Excel program for years and is now offering that expertise to help other independent physician groups get programs up and running.

O’Neill added that Revo provides consulting services and an in-house developed tool to help providers flag patients who are at risk for complications or who may need extra care. The company also advises groups on how to run surgery centers and provides other services.

Spine, Hips and Knees

This isn’t just about spine products. Last May Medtronic bought a Minnesota hip and knee replacement startup, Responsive Orthopedics, founded by former Tornier CEO Doug Kohrs.

Medtronic leaders told analysts it planned to use Responsive’s products to launch a joint-replacement service. Kohrs launched Responsive to develop low-cost knee and hip implants with a focus on bundled-payment programs, according to a Star Tribune profile.

As more knee, hip and spine surgeries are performed at ASCs and TCO performs many of its procedures at ASC centers rather than at hospitals, Medtronic’s investment in Revo Health is likely to garner the device maker valuable operational information to allow the company to pursue sales strategies to become a one-stop shop for ASCs.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy